BioTech

Source: globenewswire.com Novartis has received an approval from the US FDA for its drug, Egaten (triclabendazole). Egaten is used for the treatment of fascioliasis in...

Read more about AstraZeneca moves US court against Aurobindo Pharma on generic on Business Standard. : Pharma major AstraZeneca has filed a petition in a US court, alleging that Aurobindo Pharma is attempting to come out with the generic version of its patented drug Daliresp (Roflumilast Tablet 500 mcg).In a petition filed in the United...

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A...

EAST HANOVER, N.J., Nov. 16, 2018 /PRNewswire/ -- Novartis announced today that the US Food and Drug Administration (FDA) has expanded the label fo

The retailer is terminating its deal with its PBM, putting commercial and managed Medicaid beneficiaries out-of-network.

Flu sufferers now have a new option for relieving symptoms. Xofluza (baloxavir marboxil), a single-dose, oral prescription drug, was approved by the US Food and Drug Administration on Wednesday. The antiviral is the first new flu treatment approved by the FDA in nearly 20 years, said FDA Commissioner Dr. Scott Gottlieb in a statement.

Source: globenewswire.com Sanofi (NYSE: SNY) reported that its Q3 2018 financial results on October 31. Net sales for the quarter grew 3.7% to €9.39 billion...

Source: globenewswire.com The U.S. Food and Drug Administration has accepted Roche’s Biologics License Application and granted Priority Review for polatuzumab vedotin in combination with bendamustine...

Read the latest news from around the worlds on Biotechnology, Clinical Trial Results, FDA Calendar, FDA Events, FDA Device Approvals and more

Source: www.novartis.com Novartis announced the approval of Xolair (omalizumab) by the European Commission. Xolair is a prefilled syringe that patients with severe allergic asthma and chronic...